Industry Focus

Latest Episodes:

Financials: Real Estate, Buffett’s Bank Stock Buying Spree, and An Update on the War on Cash Basket Nov 19, 2018

Show notes

Do you invest in real estate? In this episode of Industry Focus: Financials, host Jason Moser sits down with the Fool’s own Matt Argersinger to talk about why this asset class can be a smart addition to investors’ portfolios. Plus, Fool.com contributor Matt Frankel, CFP sheds some light on the flurry of bank stock buying we’re seeing from Warren Buffett-led Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B). Finally, it’s been a rocky month or so for our “War on Cash” basket of stocks, but that doesn’t mean there’s anything wrong with these companies business-wise.

Check out more of our content here:

Or, reach us by email @ IndustryFocus@fool.com

Thanks to Molekule for supporting our channel. Get $75 off your first order at molekule.com code fool.

Tech: Is Docusign a Buy? Nov 16, 2018

Show notes

Pen and paper is the way of the past. Docusign is trying to bring contracts into the 21st century with digital signatures and document management. Early indications are that the company is onto something, but should the stock be on your watchlist?

Stocks: DOCU, UPWK

Check out more of our content here:

Or, reach us by email @ IndustryFocus@fool.com

Thanks Netsuite. Get the FREE guide, “Crushing the Five Barriers to Growth”, at NetSuite.com/Fool.

Energy: Floating the Midstream Nov 15, 2018

Show notes

On today's episode, we discuss midstream pipeline companies and the opportunities they present for investors. In addition, we discuss how the fires blazing through California are affecting the state's largest utility

Stocks Mentioned: PCG, CEQP, CHK, RDS-A, RDS-B, SHLX, WMB, BIP, ENB, PAA, MMP

Check out more of our content here:

Or, reach us by email @ IndustryFocus@fool.com

Healthcare: Let's Talk Telemedicine! Nov 14, 2018

Show notes

Here's how telehealth companies like Teladoc are disrupting patient diagnosis and treatment; why insurers are all-in on telemedicine; and what could be next for this fast-growing industry. Stocks: TDOC, RDNT, CI, ANTM

Check out more of our content here:

Or, reach us by email @ IndustryFocus@fool.com

CG: Feeling Panicked? Try Out These Consumer Staples Nov 13, 2018

Show notes

As volatility and uncertainty roil the markets, many investors are ready to hit the sell button. But before you make an expensive mistake, consider the stability offered by gold standard names in the consumer staples sector. These businesses can cushion and diversify your portfolio in even the worst bear markets. Stocks: XLP, PG, MCD, TJX, WMT

Thanks to LinkedIn for supporting The Motley Fool. Go to www.linkedin.com/fool and get $50 off your first job post.

Financials: Cryptocurrencies, Square Earnings, and The Motley Fool’s New Personal Finance Brand Nov 12, 2018

Show notes

Are cryptocurrencies still compelling long-term investments? In this episode of Industry Focus: Financials, host Jason Moser interviews The Motley Fool’s cryptocurrency expert Aaron Bush to find out the answer. Plus, Moser and Fool.com contributor Matt Frankel, CFP discuss earnings from fintech favorite Square (NYSE: SQ), The Motley Fool’s new personal finance brand The Ascent, as well as two stocks that are on their radar this week.

Tech: Chinese Stocks Are Down Big, Are Any of Them Buys? Nov 09, 2018

Show notes

The market has not been kind to Chinese tech stocks Alibaba, Baidu, Tencent, and iQiyi in 2018. With trade war threats and local regulations eating into investor optimism, could this be a good time to scoop up shares of these beaten up companies?

Stocks: IQ, TCEHY, BABA, BIDU

Energy: Space... The Final Frontier Nov 08, 2018

Show notes

With Motley Fool's annual Foolapalooza gathering this week, we go to the Industry Focus Vault to bring back this episode. Michael Douglass and Fool.com Contributor Lou Whiteman discuss investment opportunities in the commercial space and defense industrie

Healthcare: Alkermes Super-Bad Day, and Illumina's Surprising M&A News Nov 07, 2018

Show notes

Why Alkermes once-promising depression drug failed to impress the FDA's advisory committee. Plus, how a $1.2 billion acquisition of Pacific Biosciences could move the needle at Illumina. Stocks: ALKS, ILMN, PACB

CG: Going LOCO with Under Armour and Starbucks Nov 06, 2018

Show notes

Earnings season is here, and we’re digging into three reports from the past week. First, we look at the bullish market response to results from Under Armour and Starbucks as their businesses pick up momentum heading into the holiday season. Then, we turn our attention to El Pollo Loco, the California-based fast casual restaurant chain, and its own recovery effort.

Thanks to Molekule for supporting the show. Get $75 off your first order at http://www.molekule.com code “fool”.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected